Direktorat Registrasi ObatValid

CEFTRIAXONE SODIUM

BPOM Number: GKL9520918444B1
Approved: 21 November 2024
Expiry: 16 June 2027
Form: SERBUK INJEKSI;

About This Registration

CEFTRIAXONE SODIUM is a BPOM-registered direktorat registrasi obat in Indonesia, registered under number GKL9520918444B1. Its current registration status is Valid, with the licence valid until 16 June 2027. The product is registered to INDOFARMA - INDONESIA. BPOM first approved this registration in June 2022. All registration data is sourced directly from the official BPOM public database and updated daily.

Registration Details

Application: Registrasi Obat
Packaging: DUS, 2 VIAL @ 1 G
Department: Direktorat Registrasi Obat

Retail Audit Service

Get detailed market intelligence for this product across Indonesian retail channels

Multiple cities available

Custom questionnaires

Professional shoppers

Detailed reporting

Starting from $50 per city

What's included in the audit service?

Stock availability and positioning verification

Price checking and competitor analysis

Display quality and promotional material assessment

Store condition and customer experience evaluation

Custom questions tailored to your research needs

Professional photographs and detailed reports

Registered Owners

INDOFARMA - INDONESIA
KAB. BEKASI
NPWP: 12345678910
owner
View profile →

Manufacturing Sites

INDOFARMA - INDONESIA
KAB. BEKASI
primary
View profile →

Ingredients (1)

CEFTRIAXONE SODIUM

Market Intelligence

Owner Portfolio: INDOFARMA - INDONESIA holds 195 BPOM registrations
Manufacturer Scale: INDOFARMA - INDONESIA produces 195 registered products
Registration Age: Registered for 4 years, 3 months
Expiry Status: Expires in 8 months

FDA Cross-Reference

via openFDA

Generic Name: CEFTRIAXONE SODIUM
Product Type: HUMAN PRESCRIPTION DRUG
Route of Administration: INTRAMUSCULAR

Data sourced from the U.S. FDA drug label database (openFDA). May not exactly match this product variant.

Is this your product?